Advancements in modern medicine continue to astound us, especially in the realm of nerve repair. Traditionally, severed connections between the human brain and spinal cord have been deemed irreparable, leading to permanent paralysis. However, groundbreaking research from the University of Cambridge is challenging this long-held belief.
In a remarkable study, scientists successfully cultivated miniature, interconnected human brain and spinal cord tissues in a laboratory setting. This innovative 3D circuit allowed researchers to observe the precise moment when nerve cells lose their regenerative capabilities. Surprisingly, they discovered that a common contraceptive drug could activate a genetic switch, reigniting the potential for nerve repair.
Creating a Working Human Circuit
Human neurons transmit movement signals through long fibers known as axons, which connect the brain to the spinal cord and ultimately to the muscles. During early development, these axons exhibit robust growth, but this ability diminishes as maturation occurs. To explore this phenomenon, the Cambridge team constructed a 3D "connectoid" model using human stem cells to produce pea-sized brain and spinal cord organoids, strategically placed to replicate their natural arrangement.
Remarkably, the nerve fibers from the brain organoid successfully bridged the gap to connect with the spinal cord tissue. Further experimentation with muscle clusters, or myospheres, demonstrated that electrical stimulation of the brain organoid sent signals through this lab-grown circuit, resulting in muscle contractions. This was not merely a collection of cells; it was a functional human nerve circuit.
Understanding the Limits of Regeneration
The research team maintained these circuits for over a year, allowing them to monitor the changes in regeneration as the neurons matured. They identified a critical transition around day 150 of development, akin to the mid-trimester stage of human pregnancy, when the axons' capacity to regrow sharply declined.
George Gibbons, the study's lead author, noted that less mature neurons demonstrated a greater ability to regrow fibers after injury, whereas more mature neurons exhibited a significant reduction in regenerative capacity. This observation suggests that the limitations of regeneration are inherently programmed into human neurons as they develop.
Unlocking the Potential for Repair
Upon investigating gene expression within the neurons, researchers uncovered a network of genes functioning as a maturity switch, inhibiting axon growth as neurons establish synapses. By targeting key regulators within this gene network, the team successfully restored the axons' growth potential.
In their search for potential treatments, they identified the contraceptive drug lynestrenol as a promising candidate. Although it is primarily used for contraceptive purposes, applying this drug to damaged, mature neurons significantly enhanced axon regrowth. While lynestrenol may not be the definitive solution for spinal cord injuries, it opens new avenues for research into neuron regeneration.
The findings underscore the potential to directly influence the internal growth mechanisms of neurons, representing a significant advancement in regenerative medicine. The study was published in the journal Cell Reports.
